Global Emergency Contraceptives Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Date : Mar 2018

Formats :
Report Code : PMR83649619

Category : Pharmaceutical and Healthcare
No Of Pages :
Global Emergency Contraceptives Market, provides emergency contraception methods are intended to prevent unwanted pregnancies after sexual intercourse. The commonly used emergency contraceptives are pills and copperbearing intrauterine devices. Within emergency contraceptive pills are available in 3 compositions namely, combined estrogen and progestin pills, progestinonly as Levonorgestrel pills, and antiprogestin as mifepristone pills. Emergency contraceptives are different from normal contraceptives. The mechanism of action of the emergency contraceptive methods is delaying or preventing ovulation or fertilization, which is necessary during pregnancy. Both the methods are effective only before the pregnancy implanted. These procedures are ineffective after the implantation occurred.






The global emergency contraceptives market is expected to grow at an unprecedented CAGR due to increase in the global female population. Increase in the public awareness in making right decisions about their sexual and reproductive health, technological advancements and an increase in the development of effective female contraceptive drugs and devices, and availability of products in the market might fuel the emergency contraceptives market. Furthermore, low cost of the products, rise in the adoption of modern emergency contraceptives in developing countries, ease of administration of emergency contraceptive pills, and high effectiveness and convenience in emergency contraceptive devices might boost the global emergency contraceptives market. However, adverse effects like nausea, headache associated with the emergency contraceptive pills, lack of skilled professionals for the insertion of intrauterine devices, and product failures in some cases might hamper the emergency contraceptives market.



Emergency contraceptives market segmented on the basis of drug class, and distribution channel



Based on drug class, emergency contraceptives market has been segmented into the following:

Combined estrogen and progestin pills
Progestinonly as Levonorgestrel pills
Antiprogestin as mifepristone pills
Ulipristal acetate pills


Based on the distribution channel, emergency contraceptives market has been segmented into the following:

Hospital pharmacies
Retail pharmacies
Online pharmacies
Others


Market players investing heavily to manufacture emergency contraceptives to increase their share in the emergency contraceptives market. Launching of new products, collaborations, acquisitions and mergers, approvals as over the counter OTC product from various drug regulators such as U.S. Food and Drug Administration, and research and developments are some key strategies followed by various pharmaceutical companies to increase the share in the global emergency contraceptives market. For instance, in August 2010, U.S. Food and Drug Administration approved the Ella Ulipristal acetate pills as emergency contraceptive pills which are developed by HRA pharmaceuticals. Similarly, In February 2011, Teva Pharmaceuticals received an approval from the FDA for requesting nonprescription status for Plan B OneStep for women under the age of 17.



Geographically, the emergency contraceptives market has been segmented into following regions Viz. North America, Europe, AsiaPacific, Latin America, and Middle East & Africa. North America expected to account for the major market share in the Emergency Contraceptives market followed by Europe and AsiaPacific. This dominance in the North America region is owing to increase the emergency contraception EC market in U.S. driven by rising demand and less stringent market regulations. According to the Centres for Disease Control and Prevention CDC, about 4% of women aged 1544 have used emergency contraceptives in 2002, and it has increased to 11% from 20062010. Europe holds a key share in global emergency contraceptives market attributed to increasing the awareness about the use of pills, and ease of administration of the devices. A rise in the adoption of advanced contraceptives in emerging economies is the prime driving factor of the market. AsiaPacific is an emerging region for emergency contraceptives market owing to increase in female population majorly in India and China. Low cost of the products and availability of drugs over the counter also fuel the emergency contraceptives market in AsiaPacific region.



Some of the players in the emergency contraceptives market are Genetics NV Belgium, Teva Pharmaceutical Industries Ltd. Israel, Uniprix group Canada, Gavis Pharmaceuticals LLC, A Lupin Group Company U.S., HRA Pharma Paris, and Mankind Pharma India to name a few.
1. Executive Summary
2. Global Emergency Contraceptives Market Introduction
2.1. Global Emergency Contraceptives Market – Taxonomy
2.2. Global Emergency Contraceptives Market –Definitions
2.2.1. Drugs
2.2.2. Distribution Channel
3. Global Emergency Contraceptives Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Emergency Contraceptives Market Dynamics – Factors Impact Analysis
3.6. Global Emergency Contraceptives Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.7. Global Emergency Contraceptives Market – Product Pipeline Analysis
4. Global Emergency Contraceptives Market Analysis, 2013 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
4.2. YearoverYear YoY Growth Analysis %
4.3. Market Oppurtunity Analysis
5. Global Emergency Contraceptives Market, By Drugs, 2013 2017 and Forecast, 2018 2024
5.1. Combined estrogen and progestin pills
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.1.3. Market Opportunity Analysis
5.2. Progestinonly as Levonorgestrel pills
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.2.3. Market Opportunity Analysis
5.3. Antiprogestin as mifepristone pills
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.3.3. Market Opportunity Analysis
5.4. Ulipristal acetate pills
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.4.3. Market Opportunity Analysis
6. Global Emergency Contraceptives Market Forecast, By Distribution Channel, 2013 2017 and Forecast, 2018 2024
6.1. Hospital Pharmacies
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Retail Pharmacies
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
6.3. Online Pharmacies
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.3.3. Market Opportunity Analysis
7. Global Emergency Contraceptives Market Forecast, By Region, 2013 2017 and Forecast, 2018 2024
7.1. North America
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
7.3. AsiaPacific
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.5.3. Market Opportunity Analysis
7.6. Global Emergency Contraceptives Market Opportunity Analysis Index, By Drugs, By Distribution Channel, and Region, 2018 – 2024
8. North America Emergency Contraceptives Market Analysis, 2013 2017 and Forecast, 2018 2024
8.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
8.1.1. Combined Estrogen and Progestin Pills
8.1.2. Progestinonly as Levonorgestrel Pills
8.1.3. Antiprogestin as mifepristone Pills
8.1.4. Ulipristal Acetate Pills
8.1.5. Others
8.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
8.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
8.3.1. U.S.
8.3.2. Canada
8.4. North America Emergency Contraceptives Market Opportunity Analysis Index, By Drugs, By Distribution Channel and Country, 2018 – 2024
8.5. North America Emergency Contraceptives Market Dynamics – Trends
9. Europe Emergency Contraceptives Market Analysis, 2013 2017 and Forecast, 2018 2024
9.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
9.1.1. Combined Estrogen and Progestin Pills
9.1.2. Progestinonly as Levonorgestrel Pills
9.1.3. Antiprogestin as mifepristone Pills
9.1.4. Ulipristal Acetate Pills
9.1.5. Others
9.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Pharmacies
9.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Emergency Contraceptives Market Opportunity Analysis Index, Opportunity Analysis Index, By Drugs, By Distribution Channel and Country, 2018 – 2024
9.5. Europe Emergency Contraceptives Market Dynamics – Trends
10. AsiaPacific Emergency Contraceptives Market Analysis, 2013 2017 and Forecast, 2018 2024
10.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
10.1.1. Combined Estrogen and Progestin Pills
10.1.2. Progestinonly as Levonorgestrel Pills
10.1.3. Antiprogestin as mifepristone Pills
10.1.4. Ulipristal Acetate Pills
10.1.5. Others
10.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
10.2.1. Hospital Pharmacies
10.2.2. Retail Pharmacies
10.2.3. Online Pharmacies
10.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn,
YoY Growth %, and Market Share %
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of AsiaPacific
10.4. AsiaPacific Emergency Contraceptives Market Opportunity Analysis Index, By Drugs, By Distribution Channel and Country, 2018 – 2024
10.5. AsiaPacific Emergency Contraceptives Market Dynamics – Trends
11. Latin America Emergency Contraceptives Market Analysis, 2013 2017 and Forecast, 2018 2024
11.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
11.1.1. Combined Estrogen and Progestin Pills
11.1.2. Progestinonly as Levonorgestrel Pills
11.1.3. Antiprogestin as mifepristone Pills
11.1.4. Ulipristal Acetate Pills
11.1.5. Others
11.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.2.1. Hospital Pharmacies
11.2.2. Retail Pharmacies
11.2.3. Online Pharmacies
11.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Emergency Contraceptives Market Opportunity Analysis Index, By Drugs, By Distribution Channel and Country, 2018 – 2024
11.5. Latin America Emergency Contraceptives Market Dynamics – Trends
12. Middle East and Africa Emergency Contraceptives Market Analysis, 2013 2017 and Forecast, 2018 2024
12.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
12.1.1. Combined Estrogen and Progestin Pills
12.1.2. Progestinonly as Levonorgestrel Pills
12.1.3. Antiprogestin as mifepristone Pills
12.1.4. Ulipristal Acetate Pills
12.1.5. Others
12.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth % and Market Share %
12.2.1. Hospital Pharmacies
12.2.2. Retail Pharmacies
12.2.3. Online Pharmacies
12.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
12.3.1. Gulf Cooperation Council GCC Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Emergency Contraceptives Market Opportunity Analysis Index, By Drugs, By Distribution Channel and Country, 2018 – 2024
12.5. MEA Emergency Contraceptives Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis
13.2.1. Gynetics NV Belgium
13.2.2. Teva Pharmaceutical Industries Ltd. Israel
13.2.3. Uniprix group Canada
13.2.4. Gavis Pharmaceuticals LLC, A Lupin Group Company U.S.
13.2.5. HRA Pharma Paris
13.2.6. Mankind Pharma India
14. Research Methodology
15. Key Assumptions and Acronyms
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to choose PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....

About Report

Planet Market Reports added Latest and detailed market study report that focuses on “Global Emergency Contraceptives Market" Which offers essential information based on fresh ideas into Global Emergency Contraceptives Market industry along with unique market analysis which covers current top Manufactures in Global Emergency Contraceptives Market, growth, Consumption Demand, challenges, Historical data, subjects wise Survey of each chapters, Regional Insights, and Advancing industry trends, which will help our clients to aim Global Emergency Contraceptives Market. In addition, the report helps the customers to get a brief idea about Future demand and specifications of products which ensures the driving long-term income and productivity of global market.